ario pharma raises $3.1 million in funding - MarketLine Financial Deals

ario pharma raises $3.1 million in funding

ario pharma raises $3.1 million in funding - MarketLine Financial Deals
ario pharma raises $3.1 million in funding
Published Dec 11, 2013
3 pages — Published Dec 11, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

ario pharma, Ltd., a UK-based developer of drugs for the treatment of respiratory indications, has raised GBP1.9 million in funding from New Science Ventures, LLC, Forbion Capital Partners and Seroba Kernel Life Sciences Limited.

  
Source:
Document ID
MA143872_131216
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "ario pharma raises $3.1 million in funding" Dec 11, 2013. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/ario-pharma-raises-3-1-million-in-funding-2052-99538>
  
APA:
MarketLine Financial Deals. (2013). ario pharma raises $3.1 million in funding Dec 11, 2013. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/ario-pharma-raises-3-1-million-in-funding-2052-99538>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.